ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
1/1
4 files

A Pathogen Mimetic Molecule Induces Highly Amplified Synergistic Immune Activation to Vaccination via Activation of Multiple Signaling Pathways

preprint
submitted on 16.10.2020, 20:02 and posted on 19.10.2020, 10:26 by naorem nihesh, Saikat Manna, Bradley Studnitzer, Jingjing Shen, Aaron Esser-Kahn
We developed a small-molecule trimeric PRR agonist-based adjuvant inspired by the stimulation pattern of a pathogen. This molecule generated by covalently linking TLR2/6 agonist, NOD2 agonist, and NLRP3 inflammasome activator, stimulates multiple subfamilies of PRRs in a spatially defined manner resulting in an amplified innate immune response in vitro. Moreover, it elicits both stronger humoral and cellular immune responses in vivo.

Funding

NIH (5U01AI124286-05)

History

Email Address of Submitting Author

aesserkahn@uchicago.edu

Institution

University of chicago

Country

United States of America

ORCID For Submitting Author

0000-0003-1273-0951

Declaration of Conflict of Interest

No conflict of interest

Exports